更正：在哮喘小鼠模型中使用可溶性环氧化物水解酶抑制剂对气道高反应性和炎症进行新型气雾剂治疗。
Correction: Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitor.
作者信息
Zhang Chuanzhen, Li Wei, Li Xiyuan, Wan Debin, Mack Savannah, Zhang Jingjing, Wagner Karen, Wang Chang, Tan Bowen, Chen Jason, Wu Ching-Wen, Tsuji Kaori, Takeuchi Minoru, Chen Ziping, Hammock Bruce D, Pinkerton Kent E, Yang Jun
出版信息
PLoS One. 2024 Jul 17;19(7):e0307533. doi: 10.1371/journal.pone.0307533. eCollection 2024.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0266608.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0266608。]
相似文献
1
Correction: Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitor.更正：在哮喘小鼠模型中使用可溶性环氧化物水解酶抑制剂对气道高反应性和炎症进行新型气雾剂治疗。
PLoS One. 2024 Jul 17;19(7):e0307533. doi: 10.1371/journal.pone.0307533. eCollection 2024.
2
Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice.可溶性环氧化物水解酶抑制剂可减轻小鼠的炎症和气道高反应性。
Am J Respir Cell Mol Biol. 2015 Jan;52(1):46-55. doi: 10.1165/rcmb.2013-0440OC.
3
Mast cell involvement in the adenosine mediated airway hyper-reactivity in a murine model of ovalbumin-induced lung inflammation.在卵清蛋白诱导的肺部炎症小鼠模型中，肥大细胞参与腺苷介导的气道高反应性。
Br J Pharmacol. 2005 Aug;145(7):845-52. doi: 10.1038/sj.bjp.0706271.
4
Inhibition of soluble epoxide hydrolase relieves adipose inflammation via modulating M1/M2 macrophage polarization to alleviate airway inflammation and hyperresponsiveness in obese asthma.可溶性环氧化物水解酶抑制减轻脂肪炎症通过调节 M1/M2 巨噬细胞极化缓解肥胖哮喘的气道炎症和高反应性。
Biochem Pharmacol. 2024 Jan;219:115948. doi: 10.1016/j.bcp.2023.115948. Epub 2023 Nov 30.
5
Correction: Picroside II Attenuates Airway Inflammation by Downregulating the Transcription Factor GATA3 and Th2-Related Cytokines in a Mouse Model of HDM-Induced Allergic Asthma.更正：在屋尘螨诱导的过敏性哮喘小鼠模型中，胡黄连苷II通过下调转录因子GATA3和Th2相关细胞因子减轻气道炎症。
PLoS One. 2017 Jan 20;12(1):e0170832. doi: 10.1371/journal.pone.0170832. eCollection 2017.
6
Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model.抑制可溶性环氧化物水解酶可减轻慢性哮喘模型中的气道重塑。
Eur J Pharmacol. 2020 Feb 5;868:172874. doi: 10.1016/j.ejphar.2019.172874. Epub 2019 Dec 19.
7
Correction: Low Dose Aerosol Fitness at the Innate Phase of Murine Infection Better Predicts Virulence amongst Clinical Strains of Mycobacterium tuberculosis.更正：小鼠感染初期的低剂量气溶胶适应性能更好地预测结核分枝杆菌临床菌株的毒力。
PLoS One. 2019 Sep 17;14(9):e0222794. doi: 10.1371/journal.pone.0222794. eCollection 2019.
8
ZDHXB-101 (3',5-Diallyl-2, 4'-dihydroxy-[1,1'-biphen-yl]-3,5'-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways.ZDHXB-101（3'，5-二烯丙基-2,4'-二羟基-[1,1'-联苯]-3,5'-二醛）通过抑制丝裂原活化蛋白激酶和信号转导及转录激活因子 3 信号通路的激活，来防止气道重塑和高反应性。
Respir Res. 2020 Jan 13;21(1):22. doi: 10.1186/s12931-020-1281-x.
9
Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice.咪喹莫特是咪唑并喹啉胺家族中的一种新型免疫反应调节剂，可抑制小鼠体内变应原诱导的Th2反应、气道炎症和气道高反应性。
Clin Exp Allergy. 2004 Aug;34(8):1314-20. doi: 10.1111/j.1365-2222.2004.02023.x.
10
Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo.索拉非尼具有可溶环氧化物水解酶抑制活性，这有助于其在体内的作用谱。
Mol Cancer Ther. 2009 Aug;8(8):2193-203. doi: 10.1158/1535-7163.MCT-09-0119. Epub 2009 Aug 11.
本文引用的文献
1
Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitor.一种可溶性环氧化物水解酶抑制剂对哮喘小鼠模型气道高反应性和炎症的新型气溶胶治疗。
PLoS One. 2022 Apr 20;17(4):e0266608. doi: 10.1371/journal.pone.0266608. eCollection 2022.
Zotero 插件